CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $638K invested in Can-Fite BioPharma in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$340K
2
+$131K
3
+$44.2K
4
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
+$1.23K
5
SHIM
Stone House Investment Management
Pennsylvania
+$1.03K

Top Sellers

1
-$31.9K
2
-$1.22K
3
-$140
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$340K
2
$204K
3
$44.2K
4
$40.7K
5
$6.6K
6
$1.24K
7
$1.22K
8
$1.03K
9
$54
10
–
11
–
12
–